DFW Capital Partners is pleased to announce that its existing portfolio company, Evolution Research Group (“ERG”), has acquired Endeavor Clinical Trials (“ECT”), of San Antonio, Texas. ECT has over 20 years of experience conducting over 185 clinical trials, specializing in post-operative pain, neuropathic pain, podiatry, and vaccine research, among others.
Endeavor Clinical Trials is comprised of a clinical operations team of more than 45 and is led by Dr. Richard A. Pollak, who will remain with the company and continue to act as Principal Investigator. Dr. Pollak is key opinion leader in podiatry, is board-certified by the American Board of Foot and Ankle Surgery. Overseeing the clinical trial operations at Endeavor is Denise Roberts, Executive Director of Clinical Operations and Site Development at ERG and a leader in the field of analgesic research. Denise joined ERG several months ago and is spearheading the integration efforts, working closely with ERG’s clinical operations and quality assurance teams.
ERG’s Chief Executive Officer, Lori Wright explained the strategic value of ECT joining the ERG family of portfolio companies, stating “ECT’s excellent reputation in the industry, and more specifically in the field of postoperative pain research, adds tremendous value to ERG’s established leadership position in the field of neuroscience research.” As ERG continues to diversify within the CNS research space, Ms. Wright also commented, “The postoperative pain expertise that Richard, Denise and the ECT team bring to ERG nicely complements our psychiatry, neurology, addiction, sleep and early phase capabilities and broadens our service offering to the industry.”
With this acquisition, ERG has now completed four strategic add-on acquisitions since DFW’s initial investment in April 2014. ERG now owns and operates eight research units and is the largest, privately-held clinical research site company in the United States.
The acquisition was completed with additional debt financing from ERG’s existing senior lender, Benefit Street Partners L.L.C.
About DFW Capital Partners
DFW Capital Partners is a private equity investment firm focused on lower middle-market companies. The firm concentrates on service companies, with an emphasis on healthcare and outsourced business and industrial support services. DFW has established a 20+ year track record of success in both building companies. DFW is headquartered in Teaneck, NJ, and maintains an office in Chevy Chase, MD. For more information contact Keith Pennell, Managing Partner, at (201) 836-6000.